Suchergebnisse - (Person:"Liang, Tingbo")

PubPharm (460)

131

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

132

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

133

COMPOSITION FOR TREATING PANCREATIC CANCER AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von LIANG TINGBO | BAI XUELI | SHEN YINAN | +8

134

Method for establishing pancreatic cancer screening model based on mass spectrum flow technology

enthalten in: Europäisches Patentamt | 2022

von LIANG TINGBO | ZHANG QI | YE MAO

135

Method for establishing liver cancer screening model based on mass spectrum flow technology

enthalten in: Europäisches Patentamt | 2022

von LIANG TINGBO | ZHANG QI | YE MAO

136

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer : a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

137

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

138

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

139

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

enthalten in: Liver cancer | 2022

von Sun, J. | Guo, R. | Bi, X. | +53

140

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model

enthalten in: Cancer letters | 2022

von Li, P. | Rozich, N. | Wang, J. | +15